Imagin Medical Inc. (OTCMKTS:IMEXF – Get Rating) was the target of a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 20,600 shares, a growth of 45.1% from the November 30th total of 14,200 shares. Based on an average daily trading volume, of 23,500 shares, the short-interest ratio is presently 0.9 days.
Imagin Medical Price Performance
IMEXF remained flat at C$0.20 on Friday. 30 shares of the company's stock traded hands, compared to its average volume of 8,912. Imagin Medical has a twelve month low of C$0.07 and a twelve month high of C$0.44. The business has a 50-day simple moving average of C$0.14 and a two-hundred day simple moving average of C$0.18.
Get Imagin Medical alerts:Imagin Medical Company Profile
(Get Rating)
Imagin Medical Inc, a urologic oncology company, focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It offers the i/Blue Imaging System, which detects bladder cancer with advanced proprietary optics and light sensors; and enCage Coil, a disposable and focal therapy precision ablation device for use in the treatment of prostate cancer.See Also
- Get a free copy of the StockNews.com research report on Imagin Medical (IMEXF)
- MarketBeat: Week in Review 12/26 – 12/30
- The Dogs Of Tech: It's Time For A Bite Of These Stocks
- Does This Acquisition Make Microsoft a Bear Market Buy?
- Is Kintara Therapeutics A Hidden Gem?
- Should You Warm up to Generac Stock for the Winter?
Receive News & Ratings for Imagin Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imagin Medical and related companies with MarketBeat.com's FREE daily email newsletter.